Kymera Therapeutics Net Change in PP&E (Quarterly) Analysis

Kymera Therapeutics, Inc. (KYMR)

83.99 +4.36 (+5.48%) USD | NASDAQ | Dec 19, 16:00

84.08 +0.09 (+0.11%) Pre-Market: 20:00

View Net Change in PP&E (Quarterly) for KYMR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Change in PP&E (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Change in PP&E (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Change in PP&E (Quarterly) Benchmarks

Start Trial

Gilead Sciences, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade
Cytokinetics, Inc.	Upgrade
TG Therapeutics, Inc.	Upgrade
Protagonist Therapeutics, Inc.	Upgrade